Toward Healthy Drug Policy in the United States — The Case of Safehouse
Genre
Journal articleDate
2020-02-02Author
Burris, Scott
Anderson, Evan
Davis, Corey S.
Beletsky, Leo
Group
Center for Public Health Law Research (Temple University Beasley School of Law)Department
LawSubject
Drug controlDrug abuse--Government policy
Opioids--Overdose--United States--Prevention
Opioid abuse--United States
Permanent link to this record
http://hdl.handle.net/20.500.12613/7412Metadata
Show full item recordDOI
https://www.nejm.org/doi/10.1056/NEJMp1913448Description
A new Perspective article in the New England Journal of Medicine examines a recent decision by a Philadelphia judge to reject the argument that an overdose prevention site, called Safehouse, would violate the Controlled Substances Act.The decision signals a move toward an approach to regulating drugs that minimizes both the harms of drugs and the harms caused by regulation itself – worthy goals all around, the authors write.Citation
Scott Burris et al., Toward Healthy Drug Policy In The United States — The Case Of Safehouse, 382 New Eng. J. of Med. 4 (2020).Citation to related work
Massachusetts Medical SocietyFrom New England Journal of Medicine, Scott Burris, Evan Anderson, Corey S. Davis, Leo Beletsky, Toward Healthy Drug Policy In The United States — The Case Of Safehouse, 382, 4-5. Copyright © 2020 Massachusetts Medical Society. Reprinted with permission.